These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38182818)

  • 21. Treatment-induced arteriolar revascularization and miR-126 enhancement in bone marrow niche protect leukemic stem cells in AML.
    Zhang B; Nguyen LXT; Zhao D; Frankhouser DE; Wang H; Hoang DH; Qiao J; Abundis C; Brehove M; Su YL; Feng Y; Stein A; Ghoda L; Dorrance A; Perrotti D; Chen Z; Han A; Pichiorri F; Jin J; Jovanovic-Talisman T; Caligiuri MA; Kuo CJ; Yoshimura A; Li L; Rockne RC; Kortylewski M; Zheng Y; Carlesso N; Kuo YH; Marcucci G
    J Hematol Oncol; 2021 Aug; 14(1):122. PubMed ID: 34372909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CXCR4 chemokine receptor signaling induces apoptosis in acute myeloid leukemia cells via regulation of the Bcl-2 family members Bcl-XL, Noxa, and Bak.
    Kremer KN; Peterson KL; Schneider PA; Meng XW; Dai H; Hess AD; Smith BD; Rodriguez-Ramirez C; Karp JE; Kaufmann SH; Hedin KE
    J Biol Chem; 2013 Aug; 288(32):22899-914. PubMed ID: 23798675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decitabine enhances targeting of AML cells by CD34
    Cany J; Roeven MWH; Hoogstad-van Evert JS; Hobo W; Maas F; Franco Fernandez R; Blijlevens NMA; van der Velden WJ; Huls G; Jansen JH; Schaap NPM; Dolstra H
    Blood; 2018 Jan; 131(2):202-214. PubMed ID: 29138222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving chemotherapeutic efficiency in acute myeloid leukemia treatments by chemically synthesized peptide interfering with CXCR4/CXCL12 axis.
    Li X; Guo H; Duan H; Yang Y; Meng J; Liu J; Wang C; Xu H
    Sci Rep; 2015 Nov; 5():16228. PubMed ID: 26538086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combining 5-azacitidine with the E-selectin antagonist uproleselan is an effective strategy to augment responses in myelodysplasia and acute myeloid leukaemia.
    Enjeti AK; Fogler WE; Smith TAG; Lincz LF; Bond DR; Magnani JL
    Br J Haematol; 2024 Jun; 204(6):2264-2274. PubMed ID: 38659295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The bone marrow microenvironment - Home of the leukemic blasts.
    Shafat MS; Gnaneswaran B; Bowles KM; Rushworth SA
    Blood Rev; 2017 Sep; 31(5):277-286. PubMed ID: 28318761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional CXCR4-expressing microparticles and SDF-1 correlate with circulating acute myelogenous leukemia cells.
    Kalinkovich A; Tavor S; Avigdor A; Kahn J; Brill A; Petit I; Goichberg P; Tesio M; Netzer N; Naparstek E; Hardan I; Nagler A; Resnick I; Tsimanis A; Lapidot T
    Cancer Res; 2006 Nov; 66(22):11013-20. PubMed ID: 17108140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential usage of VLA-4 and CXCR4 by CD3+CD56+ NKT cells and CD56+CD16+ NK cells regulates their interaction with endothelial cells.
    Franitza S; Grabovsky V; Wald O; Weiss I; Beider K; Dagan M; Darash-Yahana M; Nagler A; Brocke S; Galun E; Alon R; Peled A
    Eur J Immunol; 2004 May; 34(5):1333-41. PubMed ID: 15114666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Level of SDF-1/CXCR4 in children with acute leukemia and its significance].
    Wen Q; Chen RL; Cai KR; Lin YW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):324-6. PubMed ID: 21518481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting of CXCR3 improves anti-myeloma efficacy of adoptively transferred activated natural killer cells.
    Bonanni V; Antonangeli F; Santoni A; Bernardini G
    J Immunother Cancer; 2019 Nov; 7(1):290. PubMed ID: 31699153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A critical role of Src family kinase in SDF-1/CXCR4-mediated bone-marrow progenitor cell recruitment to the ischemic heart.
    Cheng M; Huang K; Zhou J; Yan D; Tang YL; Zhao TC; Miller RJ; Kishore R; Losordo DW; Qin G
    J Mol Cell Cardiol; 2015 Apr; 81():49-53. PubMed ID: 25655934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting CXCR4/SDF-1 axis by lipopolymer complexes of siRNA in acute myeloid leukemia.
    Landry B; Gül-Uludağ H; Plianwong S; Kucharski C; Zak Z; Parmar MB; Kutsch O; Jiang H; Brandwein J; Uludağ H
    J Control Release; 2016 Feb; 224():8-21. PubMed ID: 26742943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for the involvement of sphingosine-1-phosphate in the homing and engraftment of hematopoietic stem cells to bone marrow.
    Adamiak M; Borkowska S; Wysoczynski M; Suszynska M; Kucia M; Rokosh G; Abdel-Latif A; Ratajczak J; Ratajczak MZ
    Oncotarget; 2015 Aug; 6(22):18819-28. PubMed ID: 26299919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engineering CAR-NK cells to secrete IL-15 sustains their anti-AML functionality but is associated with systemic toxicities.
    Christodoulou I; Ho WJ; Marple A; Ravich JW; Tam A; Rahnama R; Fearnow A; Rietberg C; Yanik S; Solomou EE; Varadhan R; Koldobskiy MA; Bonifant CL
    J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34896980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CXCL12+ stromal cells as bone marrow niche for CD34+ hematopoietic cells and their association with disease progression in myelodysplastic syndromes.
    Abe-Suzuki S; Kurata M; Abe S; Onishi I; Kirimura S; Nashimoto M; Murayama T; Hidaka M; Kitagawa M
    Lab Invest; 2014 Nov; 94(11):1212-23. PubMed ID: 25199050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low L-selectin (CD62L) expression in acute myeloid leukemia correlates with a bad cytogenetic risk.
    Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Nuessler V; Schmetzer H
    Eur J Haematol; 2003 Nov; 71(5):366-76. PubMed ID: 14667200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural Killer Cell Homing and Persistence in the Bone Marrow After Adoptive Immunotherapy Correlates With Better Leukemia Control.
    Grzywacz B; Moench L; McKenna D; Tessier KM; Bachanova V; Cooley S; Miller JS; Courville EL
    J Immunother; 2019; 42(2):65-72. PubMed ID: 30489431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enforced sialyl-Lewis-X (sLeX) display in E-selectin ligands by exofucosylation is dispensable for CD19-CAR T-cell activity and bone marrow homing.
    Sánchez-Martínez D; Gutiérrez-Agüera F; Romecin P; Vinyoles M; Palomo M; Tirado N; Zanetti SR; Juan M; Carlet M; Jeremias I; Menéndez P
    Clin Transl Med; 2021 Feb; 11(2):e280. PubMed ID: 33634970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrin alpha4beta1 involvement in stromal cell-derived factor-1alpha-promoted myeloma cell transendothelial migration and adhesion: role of cAMP and the actin cytoskeleton in adhesion.
    Parmo-Cabañas M; Bartolomé RA; Wright N; Hidalgo A; Drager AM; Teixidó J
    Exp Cell Res; 2004 Apr; 294(2):571-80. PubMed ID: 15023543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct roles of mesenchymal stem and progenitor cells during the development of acute myeloid leukemia in mice.
    Xiao P; Sandhow L; Heshmati Y; Kondo M; Bouderlique T; Dolinska M; Johansson AS; Sigvardsson M; Ekblom M; Walfridsson J; Qian H
    Blood Adv; 2018 Jun; 2(12):1480-1494. PubMed ID: 29945938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.